Health
5.1
FDA Rejects Chinese Cancer Drug Over Survival Data
Published 2 d ago1 sourceEvidence: Reported
SeverityModeratePoder360Low-rated sourceUS · CN
The FDA announced a voluntary recall of 60 mg propranolol capsules due to metallic contaminants. No adverse events have been reported. The recall affects a widely used blood pressure medication, raising supply and patient-safety concerns.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Published 2 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported
Published 1 d ago4 sourcesEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported
Published 3 h ago3 sourcesEvidence: Reported
Published 18 h ago1 sourceEvidence: Reported